Integrity of the prolyl hydroxylase domain protein 2:erythropoietin pathway in aging mice

Blood Cells, Molecules, and Diseases

Volumn 45, Issue 1, 2010, Pages 9-19

  Li, Xiping ^a   Sutherland, Scott ^a   Takeda, Kotaro ^b   Fong, Guo Hua ^b   Lee, Frank S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Erythropoietin; Gene regulation; Hypoxia inducible factor; Prolyl hydroxylase domain protein; Prolyl hydroxylation

Indexed keywords

ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR; MESSENGER RNA; PHOSPHOGLYCERATE KINASE; PHOSPHOGLYCERATE KINASE 1; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROLYL HYDROXYLASE DOMAIN PROTEIN 2; PROLYL HYDROXYLASE DOMAIN PROTEIN 3; REGULATOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

AGING; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ERYTHROCYTOSIS; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE TARGETING; GROUPS BY AGE; HEMATOPOIESIS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION;

AGING; ANIMALS; ERYTHROPOIETIN; GENE DELETION; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HYPOXIA-INDUCIBLE FACTOR 1; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROCOLLAGEN-PROLINE DIOXYGENASE; RNA, MESSENGER; SIGNAL TRANSDUCTION;

MUS;

EID: 77953135754     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2010.03.003     Document Type: Article

References (43)

1. Semenza G.L. Life with oxygen. Science 2007, 318:62-64.
2. Bertout J.A., Patel S.A., Simon M.C. The impact of O2 availability on human cancer. Nat. Rev. Cancer 2008, 8:967-975.
3. Schofield C.J., Ratcliffe P.J. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 2004, 5:343-354.
4. Kaelin W.G. Von Hippel-Lindau disease. Annu. Rev. Pathol. 2007, 2:145-173.
5. Kaelin W.G. Proline hydroxylation and gene expression. Annu. Rev. Biochem. 2005, 74:115-128.
6. Mansfield K.D., Guzy R.D., Pan Y., Young R.M., Cash T.P., Schumacker P.T., Simon M.C. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. Cell Metab. 2005, 1:393-399.
7. Guzy R.D., Hoyos B., Robin E., Chen H., Liu L., Mansfield K.D., Simon M.C., Hammerling U., Schumacker P.T. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 2005, 1:401-408.
8. Brunelle J.K., Bell E.L., Quesada N.M., Vercauteren K., Tiranti V., Zeviani M., Scarpulla R.C., Chandel N.S. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab. 2005, 1:409-414.
9. Fandrey J. Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 286:R977-R988.
10. Jelkmann W. Erythropoietin after a century of research: younger than ever. Eur. J. Haematol. 2007, 78:183-205.
11. Bunn H.F. New agents that stimulate erythropoiesis. Blood 2007, 109:868-873.
12. Hodges V.M., Rainey S., Lappin T.R., Maxwell A.P. Pathophysiology of anemia and erythrocytosis. Crit. Rev. Oncol. Hematol. 2007, 64:139-158.
13. Rankin E.B., Biju M.P., Liu Q., Unger T.L., Rha J., Johnson R.S., Simon M.C., Keith B., Haase V.H. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J. Clin. Invest. 2007, 117:1068-1077.
14. Al-Sheikh M., Moradkhani K., Lopez M., Wajcman H., Prehu C. Disturbance in the HIF-1alpha pathway associated with erythrocytosis: further evidences brought by frameshift and nonsense mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene. Blood Cells Mol. Dis. 2008, 40:160-165.
15. Ladroue C., Carcenac R., Leporrier M., Gad S., Le Hello C., Galateau-Salle F., Feunteun J., Pouyssegur J., Richard S., Gardie B. PHD2 mutation and congenital erythrocytosis with paraganglioma. N. Engl. J. Med. 2008, 359:2685-2692.
16. Percy M.J., Furlow P.W., Beer P.A., Lappin T.R., McMullin M.F., Lee F.S. A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove. Blood 2007, 110:2193-2196.
17. Percy M.J., Zhao Q., Flores A., Harrison C., Lappin T.R., Maxwell P.H., McMullin M.F., Lee F.S. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc. Natl. Acad. Sci. USA 2006, 103:654-659.
18. Pappalardi M.B., Martin J.D., Jiang Y., Burns M.C., Zhao H., Ho T., Sweitzer S., Lor L., Schwartz B., Duffy K., Gontarek R., Tummino P.J., Copeland R.A., Luo L. Biochemical characterization of human prolyl hydroxylase domain protein 2 variants associated with erythrocytosis. Biochemistry 2008, 47:11165-11167.
19. Takeda K., Ho V.C., Takeda H., Duan L.J., Nagy A., Fong G.H. Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2. Mol. Cell. Biol. 2006, 26:8336-8346.
20. Takeda K., Aguila H.L., Parikh N.S., Li X., Lamothe K., Duan L.J., Takeda H., Lee F.S., Fong G.H. Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. Blood 2008, 111:3229-3235.
21. Minamishima Y.A., Moslehi J., Bardeesy N., Cullen D., Bronson R.T., Kaelin W.G. Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. Blood 2008, 111:3236-3244.
22. Kaelin W.G., Ratcliffe P.J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 2008, 30:393-402.
23. Guralnik J.M., Eisenstaedt R.S., Ferrucci L., Klein H.G., Woodman R.C. Prevalence of anemia in persons 65years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004, 104:2263-2268.
24. Agarwal N., Prchal J.T. Erythropoietic agents and the elderly. Semin. Hematol. 2008, 45:267-275.
25. Eisenstaedt R., Penninx B.W., Woodman R.C. Anemia in the elderly: current understanding and emerging concepts. Blood Rev. 2006, 20:213-226.
26. Frenkel-Denkberg G., Gershon D., Levy A.P. The function of hypoxia-inducible factor 1 (HIF-1) is impaired in senescent mice. FEBS Lett. 1999, 462:341-344.
27. Rivard A., Berthou-Soulie L., Principe N., Kearney M., Curry C., Branellec D., Semenza G.L., Isner J.M. Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J. Biol. Chem. 2000, 275:29643-29647.
28. Di Giulio C., Bianchi G., Cacchio M., Artese L., Rapino C., Macri M.A., Di Ilio C. Oxygen and life span: chronic hypoxia as a model for studying HIF-1alpha, VEGF and NOS during aging. Respir. Physiol. Neurobiol. 2005, 147:31-38.
29. Hwang I.S., Fung M.L., Liong E.C., Tipoe G.L., Tang F. Age-related changes in adrenomedullin expression and hypoxia-inducible factor-1 activity in the rat lung and their responses to hypoxia. J. Gerontol. A Biol. Sci. Med. Sci. 2007, 62:41-49.
30. Bosch-Marce M., Okuyama H., Wesley J.B., Sarkar K., Kimura H., Liu Y.V., Zhang H., Strazza M., Rey S., Savino L., Zhou Y.F., McDonald K.R., Na Y., Vandiver S., Rabi A., Shaked Y., Kerbel R., Lavallee T., Semenza G.L. Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ. Res. 2007, 101:1310-1318.
31. Ndubuizu O.I., Chavez J.C., Lamanna J.C. Increased prolyl 4-hydroxylase (PHD) expression and differential regulation of hypoxia inducible factors (HIFs) in the aged rat brain. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297:R158-R165.
32. Chang E.I., Loh S.A., Ceradini D.J., Chang E.I., Lin S.E., Bastidas N., Aarabi S., Chan D.A., Freedman M.L., Giaccia A.J., Gurtner G.C. Age decreases endothelial progenitor cell recruitment through decreases in hypoxia-inducible factor 1alpha stabilization during ischemia. Circulation 2007, 116:2818-2829.
33. Seibler J., Zevnik B., Kuter-Luks B., Andreas S., Kern H., Hennek T., Rode A., Heimann C., Faust N., Kauselmann G., Schoor M., Jaenisch R., Rajewsky K., Kuhn R., Schwenk F. Rapid generation of inducible mouse mutants. Nucleic Acids Res. 2003, 31:e12.
34. Lee P.L., Beutler E. Regulation of hepcidin and iron-overload disease. Annu. Rev. Pathol. 2009, 4:489-515.
35. Lee F.S. Genetic causes of erythrocytosis and the oxygen-sensing pathway. Blood Rev. 2008, 22:321-332.
36. Percy M.J., Lee F.S. Familial erythrocytosis: molecular links to red blood cell control. Haematologica 2008, 93:963-967.
37. Rohrbach S., Teichert S., Niemann B., Franke C., Katschinski D.M. Caloric restriction counteracts age-dependent changes in prolyl-4-hydroxylase domain (PHD) 3 expression. Biogerontology 2008, 9:169-176.
38. Rohrbach S., Simm A., Pregla R., Franke C., Katschinski D.M. Age-dependent increase of prolyl-4-hydroxylase domain (PHD) 3 expression in human and mouse heart. Biogerontology 2005, 6:165-171.
39. Goodnough L.T., Price T.H., Parvin C.A. The endogenous erythropoietin response and the erythropoietic response to blood loss anemia: the effects of age and gender. J. Lab. Clin. Med. 1995, 126:57-64.
40. Yamashita T., Ohneda O., Sakiyama A., Iwata F., Ohneda K., Fujii-Kuriyama Y. The microenvironment for erythropoiesis is regulated by HIF-2alpha through VCAM-1 in endothelial cells. Blood 2008, 112:1482-1492.
41. Scortegagna M., Morris M.A., Oktay Y., Bennett M., Garcia J.A. The HIF family member EPAS1/HIF-2alpha is required for normal hematopoiesis in mice. Blood 2003, 102:1634-1640.
42. Peyssonnaux C., Zinkernagel A.S., Schuepbach R.A., Rankin E., Vaulont S., Haase V.H., Nizet V., Johnson R.S. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J. Clin. Invest. 2007, 117:1926-1932.
43. Wrighting D.M., Andrews N.C. Iron homeostasis and erythropoiesis. Curr. Top. Dev. Biol. 2008, 82:141-167.